Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Pemphigus, Benign Familial

ClinicalTrials.gov lists 7 trials for Pemphigus, Benign Familial or a narrower condition beneath it.

MeSH D016506 Congenital / Hereditary / Neonatal C16 C17 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 2 Phase 2 Phase 2 1 Not applicable Not applicable 1 Observational Observational 2 Expanded access Expanded access 1 Phase 1 Phase 1 2 Phase 2 Phase 2 1 Not applicable Not applicable 1 Observational Observational 2 Expanded access Expanded access 1

Trials per phase

7 of the 7 trials are tagged with Pemphigus, Benign Familial itself; the rest are tagged with a narrower condition beneath it.

Get the Pemphigus, Benign Familial report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Pemphigus, Benign Familial trials start? (6)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 2
  • Not applicable
  • Observational

Top of scale: 1

1994: 1 trials (Observational 1) 2015: 1 trials (Phase 1 1) 2018: 1 trials (Not applicable 1) 2020: 1 trials (Observational 1) 2025: 1 trials (Phase 2 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 1
2025 1
2020 1
2018 1
2015 1
1994 1

No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Pemphigus, Benign Familial trials in? (5)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 2
Phase 2 1
Not applicable 1
Observational 2
Expanded access 1

How many Pemphigus, Benign Familial trials are recruiting? (3)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 2
Available 1
Completed 4

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Pemphigus, Benign Familial trials? (3)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Krystal Biotech, Inc. 1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 1
Regeneron Pharmaceuticals 1

Which publications cover Pemphigus, Benign Familial? (2)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Botulinum toxin injections as an effective treatment for patients with intertriginous Hailey-Hailey or Darier disease: an open-label 6-month pilot interventional study. Orphanet journal of rare diseases 2021 Yes
The uses of naltrexone in dermatologic conditions. Journal of the American Academy of Dermatology 2019 No

Prevalence (3)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Hailey-Hailey disease Point prevalence 1-9 / 100 000 Worldwide Not stated Unspecified
Hailey-Hailey disease Point prevalence 1-9 / 100 000 Worldwide Not stated Exact
Hailey-Hailey disease Point prevalence 1-9 / 100 000 Worldwide Not stated Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Hailey-Hailey disease 2841 Exact Orphanet Rare Disease Ontology (ORDO)
Hailey-Hailey disease 2841 Exact Orphadata Science knowledge files, Product 1

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages